Social media is integrated into the daily lives of consumers, often engaging with brands for customer service support – except when it comes to pharmaceutical companies.

Lurking behind all the sound and fury in the political realm, 2017 is bringing new opportunities to marketers that have nothing at all to do with orange hair. A whole generation of technologies are growing to maturity together – predictive targeting, virtual reality, behavioral science, interactive video, big data, and more – all of which are transforming the ways in which brands can communicate with their audiences. But of course politics will matter too in this Year One of the Trump administration, as the continuing debate over drug pricing and the impact of the new president’s policies on the pharma industry remain very much up in the ai

The Coalition for Healthcare Communication (CHC) summit in Washington, D.C., in late November provided an interesting postmortem of the 2016 election, and a look into the crystal ball by some of our industry’s most knowledgeable leaders. Fast-forward to February 2017, and the crystal ball is still pretty cloudy.

Aetna and Humana would consider all available options for their proposed $34 billion merger, the two U.S. health insurers said one day after a court ruled against the deal due to fears it would lower competition.

Management from 2016 Manny Award winners and finalists weigh in on various industry topics presented to them by Med Ad News.